WILLIAMS COMPANIES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WILLIAMS COMPANIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.95B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $10.50B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $10.91B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $10.97B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $10.63B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $7.72B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $8.20B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $8.69B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $8.03B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $7.50B | Feb 21, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.90B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $12.63B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $12.00B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $17.77B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $12.78B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $7.65B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $8.14B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $8.60B | Feb 24, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.62B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.23B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $3.18B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.05B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.52B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $211.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $850.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | ($155.00M) | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $2.17B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | ($424.00M) | Feb 21, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.20B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.34B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $4.31B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $3.02B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.63B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $2.20B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.92B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $768.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $927.00M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $689.00M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $708.00M | Feb 25, 2025 |
| FY2024 | Dec 31, 2023 | $665.00M | Feb 25, 2025 |
| FY2024 | Dec 31, 2022 | $636.00M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $558.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $466.00M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $558.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $569.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $594.00M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $722.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2015 | $741.00M | Feb 22, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.90B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $4.97B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $5.94B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $4.89B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $3.95B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $3.50B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $3.69B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $3.29B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $3.09B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $4.16B | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.89B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.57B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.52B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.25B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.24B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.24B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $2.11B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $3.26B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $2.40B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $2.05B | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.57B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $54.53B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $52.63B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $48.43B | Feb 25, 2025 |
| FY2022 | Dec 31, 2021 | $47.61B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $44.17B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $46.04B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $45.30B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $46.35B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $46.84B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.81B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $12.44B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $12.40B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $11.49B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $11.42B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $11.77B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $13.36B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $14.66B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $9.66B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $4.64B | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $466.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $466.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $463.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $0 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Feb 21, 2024 |
| FY2019 | Dec 31, 2019 | $188.00M | Feb 24, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Feb 24, 2020 |
| FY2019 | Dec 31, 2017 | $47.00M | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $47.00M | Feb 26, 2016 |
| FY2015 | Dec 31, 2014 | $1.12B | Feb 26, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($12.24B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($12.40B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | ($12.29B) | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | ($13.27B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($13.24B) | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | ($12.75B) | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | ($11.00B) | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | ($10.00B) | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | ($8.43B) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($9.65B) | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $152.00M | Feb 27, 2023 |
| FY2022 | Dec 31, 2021 | $1.68B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $142.00M | Feb 28, 2022 |
| FY2021 | Dec 31, 2019 | $289.00M | Feb 28, 2022 |
| FY2021 | Dec 31, 2018 | $168.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $899.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $170.00M | Feb 24, 2020 |
| FY2018 | Dec 31, 2015 | $100.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2014 | $240.00M | Feb 22, 2018 |
| FY2016 | Dec 31, 2013 | $681.00M | Feb 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 2 | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 21, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | 2 | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 21, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.44B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.32B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.18B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.07B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.99B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.94B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.84B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $1.39B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $992.00M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $1.26B | Feb 21, 2019 |